Prof G Markets: Ozempic’s Market Impacts and Surging Bond Yields — with Downtown Josh Brown

Fast Food Impact

The rise of GLP-1 drugs like Ozempic is poised to significantly impact the fast food industry. Scott Galloway highlights that with a predicted 24% reduction in calorie intake among users, fast food giants like McDonald's could face substantial revenue declines, potentially losing $18 billion per quarter if 36 million fewer Big Macs are sold daily 1. This shift in consumer behavior could also affect beverage companies like Pepsico, as these drugs may alter addictive consumption patterns 2.

Nobody walks into an RB's and thinks this was a really good decision.

--- Scott Galloway

Additionally, the potential for reduced demand in alcohol and cigarettes further underscores the broad economic repercussions 2.

   

Economic Shifts

The economic implications of widespread Ozempic use extend beyond fast food, potentially transforming healthcare and transportation sectors. Scott Galloway notes that obesity-related costs, currently a $1.7 trillion drag on the U.S. economy, could be significantly reduced, enhancing GDP more than AI advancements 3. The pharmaceutical company behind Ozempic, Nova Nordisk, has already seen substantial growth, reflecting the drug's impact on both health and economic productivity 3.

What happens when America gets skinnier?

--- Ed Ellison

The potential decline in obesity-related health issues could also affect hospital networks and companies reliant on treating such conditions, indicating a major shift in investment strategies 4.